NEW YORK - According to IPO Vital Signs, an IPO information database, Loeb & Loeb LLP ranked #13 in the U.S. for IPO law firms representing the issuer in IPOs that closed in 2006. Securities Practice Group Chair, partner Mitch Nussbaum, was ranked # 1 IPO lawyer in the U.S. for the number of IPOs closed among lawyers representing issuers in 2006. The rankings were published as part of IPO Vital Signs league tables in the February 20, 2007 issue of their online publication, The IPO Week in Review.
In addition, Loeb & Loeb was tied for first place for the number of issuer clients they represented who completed SPAC offerings in 2006 (IPO Vital Signs). Last year the team completed SPAC deals ranging from $27 million to $225 million for clients in a range of industries in the U.S., Europe, China and India. The firm was also active in reverse mergers of Chinese companies and their ongoing securities counsel. In December 2006, Loeb & Loeb client American Oriental Bioengineering, Inc. (NYSE: AOB) became the first of this type of company to list on the New York Stock Exchange.
Loeb & Loeb’s Securities Group represents issuers and underwriters in initial public offerings (IPOs), special purpose acquisition corporation (SPAC) offerings and acquisitions, PIPEs, public companies and emerging growth private companies.
PrivateRaise.com ranked Loeb & Loeb in 11th place in the "Top 25 PIPE Investor Law Firms," providing counsel on eight deals totaling $92.1 million in 2006.
The team grew in 2006 with the addition a lateral partner, Angela M. Santora Dowd, and four Associates.
About Mitch Nussbaum
In a few short years, Loeb & Loeb partner Mitch Nussbaum has grown the firm’s international securities practice enough to warrant the hiring of several new partners and associates to service a growing client base. In August 2006 the partnership asked Nussbaum to chair Loeb & Loeb’s Securities Practice Group.
Nussbaum introduced the firm to its first Asian clients. He has represented over thirty-five Asian companies including the first Chinese, Taiwanese and Thai companies to list on the American Stock Exchange. In 2004 he forged an alliance for Loeb & Loeb with a Chinese law firm in Shanghai and Beijing that he has been working with for several years. Nussbaum is now applying his experience in taking internationally-based corporations public to new clients in the United Kingdom, India, Australia, Israel and Greece.
In the last few years, Nussbaum has been at the leading edge of a securities practice gaining favor in this country – the development of “special purpose acquisition corporations” called “SPACs,” which are investment vehicles formed to acquire an unspecified company within one year and a half of their origination. He has represented clients in nearly twenty SPAC initial public offerings, including deals for the purchase of companies in technology, energy, consumer products and media industries.
Nussbaum earned his J.D. from Syracuse University College of Law and his B.A. from the University of Rochester, and attended the London School of Economics. He lives in Scarsdale with his wife, six year old son and three year old daughter.
About IPO Vital Signs: IPO Vital Signs, an IPO research analysis tool, assists IPO professionals and pre-IPO companies with research in the IPO process. For more information visit the website: http://www.ipovitalsigns.com.
About Loeb & Loeb LLP: Loeb & Loeb LLP is a multiservice national law firm with 250 attorneys and offices in Los Angeles, New York, Chicago, and Nashville. The firm is recognized as a leading law firm in the areas of corporate and securities matters; litigation; entertainment and media law; finance; real estate; intellectual property; private equity; employment; advertising and promotions and tax and wealth services. Our clients include some of the world’s largest financial institutions, major media and entertainment companies, NYSE, NASDAQ and Amex listed public companies, advertising groups, real estate companies, and Big Four accounting firms, as well as many high net worth individuals.